EVL
Basic information
Region (hg38): 14:99971449-100144236
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the EVL gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 1 | |||||
missense | 23 | 24 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 23 | 0 | 2 |
Variants in EVL
This is a list of pathogenic ClinVar variants found in the EVL region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
14-100084763-C-T | not specified | Uncertain significance (Dec 15, 2022) | ||
14-100084784-C-T | not specified | Uncertain significance (Jun 10, 2024) | ||
14-100084791-A-G | not specified | Uncertain significance (Mar 01, 2023) | ||
14-100084793-A-G | not specified | Uncertain significance (Dec 21, 2021) | ||
14-100097485-T-C | not specified | Uncertain significance (Jun 27, 2023) | ||
14-100097497-C-T | not specified | Uncertain significance (Feb 17, 2024) | ||
14-100097530-C-T | not specified | Uncertain significance (Oct 05, 2023) | ||
14-100097531-G-A | Benign (Dec 31, 2019) | |||
14-100097619-A-G | not specified | Uncertain significance (Sep 06, 2022) | ||
14-100097651-A-C | not specified | Uncertain significance (Mar 24, 2023) | ||
14-100123541-C-A | not specified | Uncertain significance (Jan 18, 2022) | ||
14-100123547-A-G | not specified | Uncertain significance (Dec 28, 2022) | ||
14-100123593-T-A | not specified | Uncertain significance (Jun 18, 2021) | ||
14-100128539-C-T | not specified | Uncertain significance (Feb 06, 2023) | ||
14-100128603-C-T | not specified | Uncertain significance (Dec 01, 2022) | ||
14-100128659-G-A | not specified | Uncertain significance (Jun 29, 2023) | ||
14-100128710-G-A | not specified | Uncertain significance (Jan 23, 2023) | ||
14-100129572-G-A | not specified | Uncertain significance (May 05, 2023) | ||
14-100129587-A-G | not specified | Uncertain significance (Mar 06, 2023) | ||
14-100129669-A-G | not specified | Uncertain significance (Nov 21, 2023) | ||
14-100135929-C-G | Benign (Dec 31, 2019) | |||
14-100137622-C-T | not specified | Uncertain significance (Apr 28, 2023) | ||
14-100141188-C-T | not specified | Uncertain significance (Jan 23, 2023) | ||
14-100141190-G-A | not specified | Uncertain significance (Aug 14, 2023) | ||
14-100141778-G-A | not specified | Uncertain significance (Jan 03, 2024) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
EVL | protein_coding | protein_coding | ENST00000392920 | 14 | 172788 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.998 | 0.00239 | 125741 | 0 | 6 | 125747 | 0.0000239 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 1.48 | 187 | 253 | 0.738 | 0.0000152 | 2710 |
Missense in Polyphen | 101 | 140.04 | 0.72121 | 1521 | ||
Synonymous | -0.606 | 108 | 100 | 1.08 | 0.00000661 | 805 |
Loss of Function | 4.41 | 2 | 26.5 | 0.0755 | 0.00000130 | 294 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.00 | 0.00 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.0000544 | 0.0000544 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.0000356 | 0.0000352 |
Middle Eastern | 0.0000544 | 0.0000544 |
South Asian | 0.0000327 | 0.0000327 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Ena/VASP proteins are actin-associated proteins involved in a range of processes dependent on cytoskeleton remodeling and cell polarity such as axon guidance and lamellipodial and filopodial dynamics in migrating cells. EVL enhances actin nucleation and polymerization.;
- Pathway
- Developmental Biology;Signal Transduction;Generation of second messenger molecules;TCR signaling;TCR;Immune System;Adaptive Immune System;RHO GTPases Activate Formins;RHO GTPase Effectors;Signaling by Rho GTPases;Signaling by ROBO receptors;Axon guidance
(Consensus)
Recessive Scores
- pRec
- 0.167
Intolerance Scores
- loftool
- 0.185
- rvis_EVS
- -0.36
- rvis_percentile_EVS
- 28.93
Haploinsufficiency Scores
- pHI
- 0.743
- hipred
- Y
- hipred_score
- 0.853
- ghis
- 0.564
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.941
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Evl
- Phenotype
- homeostasis/metabolism phenotype; cellular phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); hematopoietic system phenotype; normal phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); immune system phenotype;
Gene ontology
- Biological process
- actin filament organization;cell surface receptor signaling pathway;nervous system development;axon guidance;actin polymerization or depolymerization;animal organ morphogenesis;negative regulation of epithelial cell migration;actin nucleation;protein homotetramerization;positive regulation of stress fiber assembly;cellular response to interferon-gamma;negative regulation of ruffle assembly
- Cellular component
- cytoplasm;cytosol;cytoskeleton;focal adhesion;membrane;lamellipodium;phagocytic vesicle
- Molecular function
- actin binding;protein binding;profilin binding;SH3 domain binding